Sildenafil Tablet
Product Images NDC 71205-473

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71205-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-473-30 (100mg 30ct)

Sildenafil 100 mg tablet label from Proficient Rx LP with NDC 71205-473-30. The label indicates a package size of 30 tablets, film-coated, rounded-diamond-shaped with debossed markings. Manufactured by Appco Pharma LLC, Piscataway, NJ, with storage instructions at 25°C (77°F). Several lot, expiration, and serial number placeholders are shown.*

FDA Label Image

Fig-6.jpg (Fig 6)

Two bar charts showing the effect of SILDENAFIL tablets and placebo on the maintenance of erection by baseline score. The x-axes represent baseline scores from 0 to 5, and the y-axes show the percentage of patients at endpoint. Different bars are segmented by scores 0 to 5 in a legend. The upper chart displays data for SILDENAFIL treatment, and the lower chart displays data for placebo.*

FDA Label Image

Fig5 (Fig5)

A line graph depicting the plasma concentration of sildenafil over time in hours after oral administration. The graph shows concentration on the y-axis (ng/mL) and time on the x-axis (hours), illustrating the absorption and decline of the drug concentration in the bloodstream for a commercial sildenafil tablet.*

FDA Label Image

Figure-7.jpg (Figure 7)

A vertical bar graph depicting the percentage of patients reporting improvement across different treatment groups. Groups include placebo, sildenafil tablets 25 mg, 50 mg, and 100 mg. The graph shows increasing improvement percentages with higher sildenafil doses, ranging from 24% for placebo to 82% for 100 mg tablets.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing the effects of Sildenafil 100 mg and placebo on systolic blood pressure (mmHg) over time post dose (hours). The x-axis shows time up to 24 hours, and the y-axis represents systolic blood pressure change from pre-dose values. Two lines depict blood pressure trends for each treatment group.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing change in SBP (mmHg) over time postdose (hours) for Doxazosin with Placebo versus Doxazosin with Sildenafil 25 mg. The graph shows data points from 0 to 8 hours illustrating trends in blood pressure changes between the two treatment groups.*

FDA Label Image

Figure3 (Figure3)

A line graph showing change in EBP (mmHg) over time postdose (hours) for two treatment groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The x-axis represents hours postdose from 0 to 8, and the y-axis represents change in EBP ranging approximately from -50 to 40 mmHg. The graph compares the effects of the two treatments over the time period.*

FDA Label Image

Figure4 (Figure4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' depicting changes in mmHg over time (hours) after dosing. Two treatments are compared: Doxazosin plus Sildenafil 100 mg and Doxazosin plus Placebo, showing blood pressure trends from 0 to 8 hours post dose.*

FDA Label Image

Str (Structure)

Chemical structure of sildenafil as shown in the image. The diagram displays the molecular framework of sildenafil, including its characteristic ring systems and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.